IGES Institut GmbH

What IGES Institut GmbH does

IGES Institut GmbH is a Berlin-based health systems research and consulting institute founded in 1979 that delivers evidence-based, data-driven analyses for German healthcare stakeholders. Its core technology stack combines epidemiological and health-economic methods, routine health insurance claims (GKV-Routinedaten) analytics — including support for projects using the FDZ Gesundheit dataset at BfArM covering approximately 73 million statutory insured persons — and demographic and workforce forecasting capabilities (e.g., physician shortage projections, nursing care demand modeling). Its practice is delivered through four capability modules: Analysis & Statistics; Designs, Data & Evaluation; Forecasting, Conceptualization & Development; and Reporting, Discussion & Publication.

The company serves four primary customer segments: political decision-makers (federal ministries, parliamentary committees), statutory and private health insurance funds (Krankenkassen), healthcare providers (Leistungserbringer such as hospitals, physicians, and nursing facilities), and healthcare industry companies (pharmaceutical and medical-technology manufacturers). It generates revenue through project-based contract research and consulting engagements rather than disclosed product pricing, acquired via a sales-led motion that targets senior decision-makers in government, GKV, provider, and industry organizations.

Since 2026, IGES Institut has operated as part of the Athagoras group following the reorganization of IGES Gruppe into three separate entities covering Health Systems (IGES Institut), Pharma (IGES Pharma), and MedTech (Athagoras MedTech). The institute also extended its international footprint via a 2026 cooperation agreement with China's National Health Development Research Center (CNHDRC). The core GTM remains direct consulting to enterprise and government clients within Germany.

Name

IGES Institut GmbH

Legal name

IGES Institut GmbH

Website

https://iges.de

Company type

Private

Founded year

1979

Operating status

Operating

Short description

Berlin-based health systems research and consulting institute founded in 1979 that delivers evidence-based, claims-data-driven analyses and forecasts to German federal government, statutory health insurance funds, healthcare providers, and healthcare industry companies as part of the Athagoras group.

Ownership category

akta.pro rank

Product category

Healthcare Research & Consulting

NAICS

Management, Scientific, and Technical Consulting Services (5416), Other Scientific and Technical Consulting Services (54169)

SIC

Services-Health Services (8000)

akta.pro primary industry

Health Systems Strengthening & Global Health Technical Assistance (BPADAEAH)

akta.pro secondary industries

Health Systems Performance & Quality Measurement (Public Sector) (HLAJANAK), Healthcare Utilization, Claims & Administrative Data Analytics (HLAJAJAK)

Keywords

• Healthcare research consulting
• Health systems analysis
• Health policy consulting
• Epidemiological research services
• Healthcare workforce forecasting

Headquarters

HQ city

Berlin

HQ country

Germany

HQ region

Europe

Offices1 record

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Technology or R&D, Operations, Marketing or Sales, Others

Revenue model

1. Research and Consulting Projects: Contract research and consulting services for government agencies, health insurance funds, and healthcare industry. Projects include health policy analysis, epidemiological studies, health economic evaluations, and system optimization recommendations.

Go-to-market motion1 record

Distribution channels1 record

Marketing channels6 records

Core offering

IGES Institut GmbH delivers healthcare systems research and consulting services based on evidence-based and data-driven analyses. It supports political decision-makers, statutory health insurance funds, healthcare providers, and healthcare industry companies with health policy analysis, epidemiological studies, health economic evaluations, workforce and demographic forecasting, and healthcare system optimization recommendations. Services are delivered through four methodological capability areas: analysis & statistics, research design/data/evaluation, forecasting/conceptualization/development, and reporting/discussion/publication.

Product overview

IGES Institut GmbH is a healthcare systems research and consulting institute operating as part of the Athagoras group. The company has organized its business fields into three distinct entities: IGES Institut (Gesundheitssysteme/Health Systems), IGES Pharma, and MedTech (Athagoras). Its core offering consists of evidence-based, data-driven analyses on healthcare provision at the highest methodological level. The service portfolio is delivered through four capability modules: Analysen & Statistik (Analysis & Statistics), Designs, Daten & Evaluation (Designs, Data & Evaluation), Prognose, Konzeption & Entwicklung (Forecasting, Conceptualization & Development), and Berichterstattung, Diskussion & Publikation (Reporting, Discussion & Publication). The company supports political decision-makers, health insurance funds, service providers, and healthcare industry companies in continuously advancing healthcare provision.

Differentiator

Problem solved

Functional benefit

Brands

• IGES Pharma: Pharmaceutical research and consulting division
• Athagoras MedTech

Products and services

• Healthcare Systems Research & Consulting (Gesundheitssysteme) Evidence-based and data-driven healthcare systems research and consulting for political decision-makers, health insurance funds, healthcare providers, and healthcare industry companies. Covers health policy analysis, epidemiological studies, health economic evaluations, and system optimization recommendations.
• Analysis & Statistics Services (Analysen & Statistik) Methodological consulting and analytical services covering statistical analysis for healthcare research and policy evaluation.
• Research Design, Data & Evaluation Services (Designs, Daten & Evaluation) Research design, data management, and evaluation services for healthcare studies and policy assessment.
• Forecasting, Conceptualization & Development Services (Prognose, Konzeption & Entwicklung) Forecasting, conceptualization, and development services for healthcare system planning, including physician shortage projections and nursing care demand modeling.
• Reporting, Discussion & Publication Services (Berichterstattung, Diskussion & Publikation) Reporting, discussion facilitation, and publication services for disseminating healthcare research findings to stakeholders and the public.

Quantifiable outcome

• Projection that physician shortage will grow from 4,400 unfilled positions in 2024 to 12,000 by 2040
• +2 more outcomes

Named customers4 records

Segments4 records

Ideal customer profiles4 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature3 records

Partnerships

One partnership is on record.

• National Health Development Research Center (CNHDRC)significantStrategic or Co-development Partner · 29 May 2026The IGES Institut and the Chinese National Health Development Research Center (CNHDRC) signed a cooperation agreement. CNHDRC is an institution directly subordinate to the National Health Commission (NHC) of the People's Republic of China for health policy and economic research and consulting. It serves as the national competence center for healthcare and contributes to the development and evaluation of health reforms in China. This cooperation extends a previous collaboration between the two institutions.

Scale indicators3 records

Recent moves6 records

Expansion highlights4 records

Direct peers

• RAND Corporation Health Division: RAND Health conducts health systems research, policy analysis, and workforce forecasting for government and foundation clients in the US and internationally. Directly comparable to IGES in research-only mission, government-funded project mix, and forecasting/policy evaluation methodologies.
• DIW Berlin (German Institute for Economic Research): DIW Berlin is one of Germany's leading economic research institutes with a health economics department publishing on insurance markets, long-term care, and labor-market health. Comparable in public-funder client base, Berlin footprint, and policy-oriented empirical research profile to IGES.
• IQWiG (Institute for Quality and Efficiency in Health Care): IQWiG is Germany's central health technology assessment body, producing evidence-based reports for federal decision-makers on drug benefits, medical device evaluations, and disease management guidelines. Closely comparable in mandate, methodological rigor, and public-sector client base to IGES's HTA and benefit evaluation work.
• WIdO (Wissenschaftliches Institut der AOK): WIdO is the research institute of the AOK federal association, conducting health systems research, claims data analysis, and healthcare reporting in Germany. Directly comparable to IGES in methodology (claims-data analytics), customer base (statutory health insurance funds, federal ministries), and subject matter (health system performance and pharmaceutical market analysis).
• ZEW (Centre for European Economic Research): ZEW is a German economic research institute with a dedicated health economics research program covering pharmaceutical markets, health insurance, and labor-market policy. Comparable to IGES in academic-policy hybrid positioning, German public-funder client base, and empirical health economics focus.

Broad incumbents

• McKinsey Health Practice: McKinsey's global Health Practice advises ministries of health, statutory payers, and provider systems on transformation, cost containment, and workforce strategy. Overlaps with IGES on health-system reform advisory, contribution-rate stabilization work, and pharmaceutical value-chain analysis at a global scale.
• IQVIA Institute for Human Data Science: IQVIA is the global leader in healthcare data, analytics, and consulting with deep presence in pharmaceutical market access and real-world evidence. Overlaps with IGES on pharma market research, claims-data analytics, and HTA-adjacent advisory work, but at substantially greater scale and global reach.
• Deloitte Health Care Consulting: Deloitte's global healthcare practice delivers strategy, operations, and policy advisory to payers, providers, and pharma across Europe. Overlaps with IGES on health-system optimization, payer advisory, and workforce planning but offers broader management consulting capabilities and international delivery.

Regional players

• Destatis (Statistisches Bundesamt) Health Statistics Division: Destatis is Germany's federal statistical office producing official health statistics, hospital reporting, and population health indicators. Adjacent to IGES's health reporting and epidemiological analysis offerings but operating as a public authority rather than a commercial research institute.

Emerging players

• Bertelsmann Stiftung Health Program: Bertelsmann Stiftung funds and publishes major health system comparison studies, healthcare delivery reform analyses, and physician-workforce reports in Germany. Overlaps with IGES on health systems reform advisory and workforce forecasting, but operates from a foundation/funded model rather than contract research.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat4 records

Key risks6 records

Key highlights7 records

Customer concentration

Revenue estimate

Valuation estimate

Number of profiles

Profiles2 records

Subsidiaries3 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about IGES Institut GmbH